02.05.23
Benzinga
SOMAÍ’s CEO Michael Sassano shares his thoughts about the pressure and concerns surrounding Germany’s proposed regulation on cannabis, the limited acceptance of cannabis among EU members, and the potential of medicinal cannabis and experiments.
02.05.23
Cannabis Law Journal
All startups, including new pharmaceutical manufacturing facilities, need to grapple with the complexities of launching. Pharmaceutical products are a considerable challenge and require a longer-term perspective. You will face more than regulatory hurdles associated with registering pharmaceutical products and will be challenged to coordinate a talented sales team with your production capacity. We will walk you through some ideas to help you plan sales efforts more efficiently.
17.03.23
Benzinga
Thanks to Michael Sassano, CEO of SOMAÍ Pharmaceuticals, manufacturer in Europe, for his insights on the challenges and solutions to make America a global cannabis manufacturing leader.
21.02.23
ValiantCEO
Starting a business is a huge step, and it’s essential to get it right from the beginning. One of the most critical factors for a startup’s success is market research. Understanding the market you’re entering, your target audience, and what they want can make or break your business. In this article, we’ll explore the seven key roles of market research in startup success.
19.02.23
YouTube
Luckily there are folks like Michael Sassano – Founder, Chairman & CEO of SOMAÍ Pharmaceuticals and one of the most respected executives in the pharmaceutical cannabis space today – who are are committed to the journey.
17.02.23
Open Access Government
Michael Sassano, CEO at SOMAÍ Pharmaceuticals, walks us through how clarity and standards can help the CBD Industry to thrive
06.02.23
Cannabis Law Journal
The process of forecasting is complex when you want to bring a new medicine to market.
GMP processes are slow and have an intense workload for documentation of new products that depend on the country regulators’ scheduling, further complicating release forecasting for medical products.
05.02.23
KevinMD
The United States and Canada started a movement that began as medical cannabis and quickly exploded into adult-use cannabis markets. However, the North American operators failed to properly regulate the processes from growing to manufacturing to compete in a global pharmaceutical-level market.
02.02.23
Pharmaceutical Technology Europe
The European bio/pharma industry’s high regulatory standards and GMP requirements are set to position the region as a frontrunner for pharmaceutical‑grade manufacturing of cannabis-based medicines.